Bain Capital Life Sciences Investors’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,030,703
| Closed | -$9.59M | – | 26 |
|
|
2024
Q2 | $9.59M | Sell |
1,030,703
-980,984
| -49% | -$9.12M | 1.05% | 16 |
|
|
2024
Q1 | $19.9M | Sell |
2,011,687
-988,313
| -33% | -$9.79M | 1.6% | 15 |
|
|
2023
Q4 | $9.69M | Hold |
3,000,000
| – | – | 0.93% | 18 |
|
|
2023
Q3 | $15.9M | Hold |
3,000,000
| – | – | 1.78% | 14 |
|
|
2023
Q2 | $28.6M | Hold |
3,000,000
| – | – | 2.94% | 12 |
|
|
2023
Q1 | $33M | Hold |
3,000,000
| – | – | 4.12% | 9 |
|
|
2022
Q4 | $44.4M | Hold |
3,000,000
| – | – | 4.96% | 6 |
|
|
2022
Q3 | $57.3M | Hold |
3,000,000
| – | – | 6.84% | 4 |
|
|
2022
Q2 | $63.9M | Sell |
3,000,000
-979,292
| -25% | -$20.9M | 7.5% | 4 |
|
|
2022
Q1 | $76.6M | Hold |
3,979,292
| – | – | 7.44% | 3 |
|
|
2021
Q4 | $82.5M | Hold |
3,979,292
| – | – | 6.55% | 4 |
|
|
2021
Q3 | $95.1M | Hold |
3,979,292
| – | – | 5.9% | 6 |
|
|
2021
Q2 | $109M | Hold |
3,979,292
| – | – | 7.12% | 5 |
|
|
2021
Q1 | $115M | Hold |
3,979,292
| – | – | 6.52% | 3 |
|
|
2020
Q4 | $112M | Hold |
3,979,292
| – | – | 7.03% | 3 |
|
|
2020
Q3 | $117M | Hold |
3,979,292
| – | – | 10.87% | 2 |
|
|
2020
Q2 | $120M | Hold |
3,979,292
| – | – | 12.6% | 2 |
|
|
2020
Q1 | $119M | Buy |
+3,979,292
| New | +$119M | 20.05% | 2 |
|